Wave Life Sciences Ltd. - stock earnings
WVE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -16.3 million USD | 29.1 million USD |
| 2023Q3 | 7.3 million USD | 49.2 million USD |
| 2023Q2 | -21.1 million USD | 22.1 million USD |
| 2023Q1 | -24.5 million USD | 12.9 million USD |
| 2022Q4 | -43.7 million USD | 1.2 million USD |
| 2022Q3 | -39.1 million USD | 285000 USD |
| 2022Q2 | 124000 USD | 375000 USD |
| 2022Q1 | -37.5 million USD | 1.8 million USD |
| 2021Q4 | -34.8 million USD | 1.8 million USD |
| 2021Q3 | -6.2 million USD | 36.4 million USD |
| 2021Q2 | -38.8 million USD | 2.8 million USD |
| 2021Q1 | -42.5 million USD | 9.4 million USD |
| 2020Q4 | -28.8 million USD | 9.4 million USD |
| 2020Q3 | -33.1 million USD | 3.5 million USD |
| 2020Q2 | -40.5 million USD | 3.0 million USD |
| 2020Q1 | -47.5 million USD | 4.2 million USD |
| 2019Q4 | -56.8 million USD | 2.4 million USD |
| 2019Q3 | -50.7 million USD | 2.9 million USD |
| 2019Q2 | -41.9 million USD | 7.6 million USD |
| 2019Q1 | -44.2 million USD | 3.0 million USD |
| 2018Q4 | -37.9 million USD | 3.6 million USD |
| 2018Q3 | -37.6 million USD | 4.5 million USD |
| 2018Q2 | -35.9 million USD | 4.9 million USD |
| 2018Q1 | -35.2 million USD | 1.4 million USD |
| 2017Q4 | -30.2 million USD | 1.7 million USD |
| 2017Q3 | -26.1 million USD | 676000 USD |
| 2017Q2 | -24.7 million USD | 676000 USD |
| 2017Q1 | -21.0 million USD | 676000 USD |
| 2016Q4 | -18.5 million USD | 676000 USD |
| 2016Q3 | -17.5 million USD | 392000 USD |
| 2016Q2 | -11.6 million USD | 417000 USD |
| 2016Q1 | -7.8 million USD | 152000 USD |
| 2015Q4 | -7.1 million USD | 152000 USD |
| 2015Q3 | -4.9 million USD | 26000 USD |
| 2015Q2 | -3.7 million USD | 126000 USD |
| 2015Q1 | -3.5 million USD | 26000 USD |
| 2014Q4 | -1.7 million USD | ? USD |
| 2014Q3 | -1.4 million USD | ? USD |
WVE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -57.5 million USD | 113.3 million USD |
| 2022 | -161.8 million USD | 3.6 million USD |
| 2021 | -122.2 million USD | 41.0 million USD |
| 2020 | -149.9 million USD | 20.1 million USD |
| 2019 | -179.5 million USD | 16.0 million USD |
| 2018 | -146.7 million USD | 14.4 million USD |
| 2017 | -102.0 million USD | 3.7 million USD |
| 2016 | -55.4 million USD | 1.5 million USD |
| 2015 | -19.2 million USD | 152000 USD |
| 2014 | -5.2 million USD | ? USD |
| 2013 | -3.3 million USD | ? USD |
WVE
Price: $4.66
52 week price:
Earnings Per Share: -0.54 USD
P/E Ratio: -4.73
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 358300
Ebitda: -26.4 millionMarket Capitalization: 709.2 million